GGrantIndex
← Leaderboards

Steven M Dudek

University Of Florida

$14,673,278
Attributed
$16,200,868
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,200,868 · 15

By mechanism

P01$6,842,707 · 6
R01$5,529,244 · 3
T32$1,715,994 · 2
R38$1,004,390 · 1
K08$644,490 · 1
R56$421,630 · 1

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Lung

Research focus

LungInflammatorySepsisEndothelial CellsLung InjuryResearch PersonnelIn VitroIn VivoCodeSignal TransductionActinsStructureCytoskeletonMediatingCessation Of LifeRegulationSyndromeAdult Respiratory Distress SyndromePermeabilityAcutePre-Clinical ModelAcute Lung InjuryResponseResolution

Grant awards (47)

Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury$662,283
R01 · FY2025 · HL · contact PI
Postdoctoral Research Training in Lung Injury and Inflammation$407,052
T32 · FY2025 · HL · contact PI
Patient Sampling and Genomics Core$359,349
P01 · FY2025 · HL · contact PI
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability$300,904
P01 · FY2025 · HL · contact PI
Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury$649,037
R01 · FY2024 · HL · contact PI
Patient Sampling and Genomics Core$352,502
P01 · FY2024 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$333,296
R38 · FY2024 · HL
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability$294,484
P01 · FY2024 · HL · contact PI
Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury$652,674
R01 · FY2023 · HL · contact PI
Patient Sampling and Genomics Core$359,349
P01 · FY2023 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2023 · HL
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability$313,113
P01 · FY2023 · HL · contact PI
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research$42,172
T32 · FY2023 · HL · contact PI
Patient Sampling and Genomics Core$362,485
P01 · FY2022 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2022 · HL
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability$314,785
P01 · FY2022 · HL · contact PI
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research$237,389
T32 · FY2022 · HL · contact PI
Patient Sampling and Genomics Core$370,938
P01 · FY2021 · HL · contact PI
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research$341,855
T32 · FY2021 · HL · contact PI
Group V Phospholipase A2 Mediates Acute Lung Injury$399,750
R01 · FY2020 · HL · contact PI
Mechanisms of Peripheral Remodeling of the EC Cytoskeleton$374,726
P01 · FY2020 · HL · contact PI
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research$351,755
T32 · FY2020 · HL · contact PI
Group V Phospholipase A2 Mediates Acute Lung Injury$399,750
R01 · FY2019 · HL · contact PI
Mechanisms of Peripheral Remodeling of the EC Cytoskeleton$374,726
P01 · FY2019 · HL · contact PI
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research$335,771
T32 · FY2019 · HL · contact PI
Group V Phospholipase A2 Mediates Acute Lung Injury$399,750
R01 · FY2018 · HL · contact PI
Mechanisms of Peripheral Remodeling of the EC Cytoskeleton$367,230
P01 · FY2018 · HL · contact PI
Group V Phospholipase A2 Mediates Acute Lung Injury$429,750
R01 · FY2017 · HL · contact PI
Mechanisms of Peripheral Remodeling of the EC Cytoskeleton$374,728
P01 · FY2017 · HL · contact PI
Mechanisms of Peripheral Remodeling of the EC Cytoskeleton$360,105
P01 · FY2016 · HL · contact PI
Cortactin in Regulation of Pulmonary Vascular Permeability$421,630
R56 · FY2015 · HL · contact PI
Therapeutic Potential of FTY720 Analogues in Lung Injury$363,953
P01 · FY2015 · HL · contact PI
Therapeutic Potential of FTY720 Analogues in Lung Injury$362,104
P01 · FY2014 · HL · contact PI
Therapeutic Potential of FTY720 Analogues in Lung Injury$394,402
P01 · FY2013 · HL · contact PI
Therapeutic Potential of FTY720 Analogues in Lung Injury$414,287
P01 · FY2012 · HL · contact PI
Therapeutic Potential of FTY720 Analogues in Lung Injury$428,537
P01 · FY2011 · HL · contact PI
Cortactin in Regulation of Pulmonary Vascular Permeability$392,500
R01 · FY2011 · HL · contact PI
Cortactin in Regulation of Pulmonary Vascular Permeability$392,500
R01 · FY2010 · HL · contact PI
Cortactin in Regulation of Pulmonary Vascular Permeability$383,750
R01 · FY2009 · HL · contact PI
Cortactin in Regulation of Pulmonary Vascular Permeability$383,750
R01 · FY2008 · HL · contact PI
Cortactin in Regulation of Pulmonary Vascular Permeability$383,750
R01 · FY2007 · HL · contact PI
Endothelial Cell Cytoskeletal Regulation by Cortactin$125,010
K08 · FY2006 · HL · contact PI
Endothelial Cell Cytoskeletal Regulation by Cortactin$125,010
K08 · FY2005 · HL
Endothelial Cell Cytoskeletal Regulation by Cortactin$131,490
K08 · FY2004 · HL
Endothelial Cell Cytoskeletal Regulation by Cortactin$131,490
K08 · FY2003 · HL
Endothelial Cell Cytoskeletal Regulation by Cortactin$131,490
K08 · FY2002 · HL
CORTACTIN IN LUNG ENDOTHELIAL CONTRACTION/PERMEABILITY$42,413
F32 · FY2000 · HL